What are the requirements for submitting sequence listings in patent applications?

What are the requirements for submitting sequence listings in patent applications?

Submitting sequence listings in patent applications involves specific requirements as outlined in MPEP 2412.01:

“Patent applications which contain disclosures of nucleotide and/or amino acid sequences must contain, as a separate part of the disclosure, a paper or compact disc copy disclosing the nucleotide and/or amino acid sequences and associated information using the symbols and format in accordance with the requirements of 37 CFR 1.821 – 1.825.”

Key requirements include:

• Sequence listings must be submitted as a separate part of the disclosure
• They can be submitted on paper or compact disc (though electronic submission is now preferred)
• The format must comply with the symbols and format specified in 37 CFR 1.821 – 1.825
• Each sequence must be assigned a unique sequence identifier (SEQ ID NO)
• The sequence listing must include relevant associated information

Applicants should carefully follow these requirements to ensure their sequence listings are properly submitted and accepted by the USPTO.

To learn more:

• sequence listings
• patent applications
• submission requirements
• biotechnology